• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在选择性球囊阻断经动脉化疗栓塞期间肝细胞癌结节中碘化油乳剂的密集积聚:球囊阻断动脉残端压力的测量。

Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.

机构信息

Department of Radiology, Hitachi General Hospital, Jyonann 2-1-1, Hitachi, Ibaraki 317-0077, Japan.

出版信息

Cardiovasc Intervent Radiol. 2013 Jun;36(3):706-13. doi: 10.1007/s00270-012-0476-z. Epub 2012 Sep 21.

DOI:10.1007/s00270-012-0476-z
PMID:22996589
Abstract

PURPOSE

To reveal the mechanism of dense accumulation of lipiodol emulsion (LE) in hepatocellular carcinoma (HCC) during selective balloon-occluded transarterial chemoembolization (B-TACE).

METHODS

Balloon-occluded arterial stump pressure (BOASP) at the embolization portion was measured during selective B-TACE for 43 nodules in 42 patients. Fluoroscopy and digital subtraction angiography were prospectively observed during selective B-TACE to note whether dense LE accumulation in HCC occurred. The LE concentration ratio of HCC to embolized liver parenchyma (LECHL ratio) was also calculated for each treatment on the basis of the computed tomographic scan obtained immediately after selective B-TACE. The relationships between degree of LE accumulation and the BOASP, as well as the LECHL ratio, were analyzed.

RESULTS

Arterial flow beyond the catheter tip was maintained even after balloon inflation. In 39 of 43 treatments, LE inflow into the nontumorous liver parenchyma ceased immediately after LE droplets were filled in arteries of the nontumorous liver parenchyma while LE inflow into the HCC nodule continued (group 1). More dense LE accumulation in HCC nodule was obtained in these 39 treatments. In four treatments, LE inflow both into the nontumorous liver parenchyma and into the HCC nodule continued, and no dense LE accumulation in HCC nodule was observed (group 2). In these four treatments, thick anastomotic vessels with collateral artery were noted. The BOASP in group 1 was (mean ± SD) 33.8 ± 12.8 mmHg (range 13-64 mmHg) and that in group 2 was 92.3 ± 7.4 mmHg (range 83-100 mmHg). There was a statistically significant difference in BOASP between groups (p = 0.00004, Welch's t test). The LECHL ratio in group 1 was 18.3 ± 13.9 (range 2.9-54.2) and that in group 2 was 2.6 ± 1.1 (range 1.7-4.2). There was a statistically significant difference in the LECHL ratio between the groups (p = 0.000034, Welch's t test).

CONCLUSION

Selective B-TACE induced dense LE accumulation in HCC nodules in 39 (91 %) of 43 treatments in which BOASP was 64 mmHg or less.

摘要

目的

揭示选择性球囊阻断经动脉化疗栓塞(B-TACE)期间碘化油乳剂(LE)在肝细胞癌(HCC)中密集积聚的机制。

方法

对 42 例 43 个结节的选择性 B-TACE 过程中栓塞部位的球囊阻断动脉残端压力(BOASP)进行了测量。在选择性 B-TACE 过程中前瞻性透视和数字减影血管造影观察是否发生 HCC 中密集的 LE 积聚。还根据选择性 B-TACE 后即刻获得的 CT 扫描计算 HCC 与栓塞肝实质(LECHL 比值)的 LE 浓度比。分析 LE 积聚程度与 BOASP 和 LECHL 比值之间的关系。

结果

即使在球囊充气后,导管尖端以外的动脉血流仍保持通畅。在 43 次治疗中的 39 次中,当 LE 液滴充满非肿瘤性肝实质的动脉时,LE 流入非肿瘤性肝实质立即停止,而 LE 流入 HCC 结节继续(第 1 组)。在这 39 次治疗中,获得了更密集的 HCC 结节中的 LE 积聚。在 4 次治疗中,LE 流入非肿瘤性肝实质和 HCC 结节都继续,并且未观察到 HCC 结节中密集的 LE 积聚(第 2 组)。在这 4 次治疗中,注意到有厚的吻合血管和侧支动脉。第 1 组的 BOASP 为(平均值±标准差)33.8±12.8mmHg(范围 13-64mmHg),第 2 组为 92.3±7.4mmHg(范围 83-100mmHg)。两组间 BOASP 差异有统计学意义(p=0.00004,Welch's t 检验)。第 1 组的 LECHL 比值为 18.3±13.9(范围 2.9-54.2),第 2 组为 2.6±1.1(范围 1.7-4.2)。两组间的 LECHL 比值差异有统计学意义(p=0.000034,Welch's t 检验)。

结论

在 BOASP 为 64mmHg 或更低的 43 次治疗中的 39 次(91%)中,选择性 B-TACE 诱导 HCC 结节中密集的 LE 积聚。

相似文献

1
Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.在选择性球囊阻断经动脉化疗栓塞期间肝细胞癌结节中碘化油乳剂的密集积聚:球囊阻断动脉残端压力的测量。
Cardiovasc Intervent Radiol. 2013 Jun;36(3):706-13. doi: 10.1007/s00270-012-0476-z. Epub 2012 Sep 21.
2
Balloon-occluded arterial stump pressure before balloon-occluded transarterial chemoembolization.球囊闭塞经动脉化疗栓塞术前的球囊闭塞动脉残端压力。
Minim Invasive Ther Allied Technol. 2016;25(1):22-8. doi: 10.3109/13645706.2015.1086381. Epub 2015 Sep 25.
3
Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma.经皮球囊阻断导管动脉化疗栓塞术(B-TACE)治疗肝细胞癌的初步经验。
Cardiovasc Intervent Radiol. 2016 Mar;39(3):359-66. doi: 10.1007/s00270-015-1237-6. Epub 2015 Dec 28.
4
Balloon-occluded transarterial chemoembolization using a 1.8-French tip coaxial microballoon catheter for hepatocellular carcinoma: technical and safety considerations.使用1.8法式尖端同轴微球囊导管进行球囊闭塞经动脉化疗栓塞治疗肝细胞癌:技术与安全考量
Minim Invasive Ther Allied Technol. 2015 Apr;24(2):94-100. doi: 10.3109/13645706.2014.951657. Epub 2014 Sep 29.
5
Balloon-Occluded Trans-Arterial Chemoembolization Technique with Alternate Infusion of Cisplatin and Gelatin Slurry for Small Hepatocellular Carcinoma Nodules Adjacent to the Glisson Sheath.球囊阻塞经肝动脉化疗栓塞术联合顺铂和明胶乳剂交替灌注治疗紧邻肝蒂的小肝癌结节。
Biomed Res Int. 2019 May 9;2019:8350926. doi: 10.1155/2019/8350926. eCollection 2019.
6
C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.C形臂碘油CT在小肝细胞癌经动脉化疗栓塞术中的应用
World J Gastroenterol. 2015 Mar 14;21(10):3035-40. doi: 10.3748/wjg.v21.i10.3035.
7
Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.顺铂经动脉化疗栓塞术二线治疗对表柔比星-碘油乳剂化疗栓塞无反应的肝细胞癌。
Cardiovasc Intervent Radiol. 2012 Feb;35(1):82-9. doi: 10.1007/s00270-010-0086-6. Epub 2011 Jan 4.
8
Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.载聚乙二醇表阿霉素的药物洗脱微球经皮经肝动脉化疗栓塞术(b-TACE)治疗肝细胞癌的安全性和初步结果。
Cardiovasc Intervent Radiol. 2019 Jun;42(6):853-862. doi: 10.1007/s00270-019-02192-y. Epub 2019 Mar 6.
9
Hemodynamic changes during balloon-occluded transarterial chemoembolization (B-TACE) of hepatocellular carcinoma observed by contrast-enhanced ultrasound.通过超声造影观察肝细胞癌经动脉球囊闭塞化疗栓塞术(B-TACE)期间的血流动力学变化。
J Med Ultrason (2001). 2014 Apr;41(2):209-15. doi: 10.1007/s10396-013-0487-7. Epub 2013 Aug 29.
10
Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: preliminary clinical experience.米立培醇脂质体混悬液经肝动脉化疗栓塞治疗肝细胞癌的初步临床经验:温热效应。
Cardiovasc Intervent Radiol. 2013 Aug;36(4):1023-9. doi: 10.1007/s00270-012-0537-3. Epub 2012 Dec 13.

引用本文的文献

1
Modern approach to hepatocellular carcinoma treatment.肝细胞癌治疗的现代方法。
World J Hepatol. 2025 Aug 27;17(8):107873. doi: 10.4254/wjh.v17.i8.107873.
2
Vesical perfusion volume and internal iliac pressure during double balloon-occluded arterial infusion chemotherapy for bladder cancer.膀胱癌双球囊阻断动脉灌注化疗期间的膀胱灌注量及髂内压力
Eur Radiol Exp. 2025 Aug 11;9(1):72. doi: 10.1186/s41747-025-00620-y.
3
Conventional vs. DEB vs. DSM: Which technique for palliative TACE in intermediate-stage HCC? Results on 70 patients in terms of efficacy and tolerance.
传统栓塞术与载药微球栓塞术与药物洗脱微球栓塞术:中期肝细胞癌姑息性经动脉化疗栓塞术采用哪种技术?70例患者的疗效和耐受性结果
Radiol Med. 2025 Aug 6. doi: 10.1007/s11547-025-02069-w.
4
Pressure Gradient-Driven Embolization b-TACE for HCC: Technical and Diagnostic Step-by-Step Procedural Guide and Literature Review.压力梯度驱动的栓塞性b-TACE治疗肝癌:技术与诊断的逐步操作指南及文献综述
Diagnostics (Basel). 2025 Jul 7;15(13):1726. doi: 10.3390/diagnostics15131726.
5
Balloon-occluded versus conventional transarterial chemoembolization for the treatment of early to intermediate stage hepatocellular carcinoma: a meta-analysis and trial sequential analysis.球囊闭塞与传统经动脉化疗栓塞治疗早期至中期肝细胞癌的Meta分析和试验序贯分析
BMC Cancer. 2025 Jul 1;25(1):1036. doi: 10.1186/s12885-025-14435-y.
6
Quantitative literature analysis on efficacy and safety of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma.经动脉化疗栓塞术治疗肝细胞癌疗效与安全性的定量文献分析
BMC Gastroenterol. 2025 Jun 4;25(1):430. doi: 10.1186/s12876-025-03851-w.
7
Transarterial Chemoembolization for Hepatocellular Carcinoma: Current Role and Techniques.经动脉化疗栓塞治疗肝细胞癌:当前的作用和技术
Interv Radiol (Higashimatsuyama). 2024 Oct 4;10:e20240016. doi: 10.22575/interventionalradiology.2024-0016. eCollection 2025 Mar 28.
8
Effective Utilization of Conventional Transarterial Chemoembolization and Drug-eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma: A Guide to Proper Usage.传统经动脉化疗栓塞术与载药微球经动脉化疗栓塞术在肝细胞癌中的有效应用:正确使用指南
Interv Radiol (Higashimatsuyama). 2023 Dec 14;10:e20230009. doi: 10.22575/interventionalradiology.2023-0009. eCollection 2025 Mar 28.
9
Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria.多中心前瞻性临床试验:针对超出米兰标准的肝细胞癌,采用球囊闭塞下顺铂溶液与明胶微粒经动脉化疗栓塞交替灌注法
Sci Rep. 2025 May 13;15(1):16502. doi: 10.1038/s41598-025-01444-x.
10
Transarterial Chemoembolization: A Consistent and Continuously Evolving Therapy for Hepatocellular Carcinoma.经动脉化疗栓塞术:一种针对肝细胞癌的持续且不断发展的治疗方法。
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102538. doi: 10.1016/j.jceh.2025.102538. Epub 2025 Mar 3.